Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
The role of a germ cell specific fatty acid binding protein in the progression of prostate cancer metastasis
FY 2023-24
Summary
Fatty acid binding protein 12 (FABP12) is the most recently discovered member of the FABP family and is important for the movement of fat molecules, or lipids, within our cells. Under normal circumstances, FABP12 is only present in the male germ-line cells, or testis, but becomes reactivated in some cancers such as prostate cancer. When expressed in cancer, FABP12 has been shown to aid in a process known as metastasis, a serious progression of the disease that makes the tumour not only harder to treat, but also deadlier. The goal of this research is to further explore the link between FABP12 and prostate cancer metastasis in order to give us a better understanding of how these tumours spread in the body, as well as look for new possible targets for cancer therapy. This will involve identifying the specific lipids that FABP12 binds to, as well as the effect that these lipids have on the ability of cancer cells to produce the much needed energy that sustains their rapid growth. In addition, this proposal aims to explore the effect of FABP12 on epigenetics, a process whereby genes are turned on and off without the gene itself being altered. The expression of FABP12 seems to be associated with an increase in molecules that are important in the flipping of these on and off switches. Intriguingly, the presence of FABP12 in prostate cancer is also associated with the expression of epigenetically-regulated Cancer Testis Antigens, which like FABP12, are normally only found in the testis. Thus, FABP12 or other Cancer Testis Antigens represent exciting new targets for therapy since they are turned off in almost all healthy tissues. A deeper understanding of the role of FABP12 in prostate cancer may help us identify specific targets for cancer therapy in the future.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506313
Name
Semeniuk Mitchell
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of a germ cell specific fatty acid binding protein in the progression of prostate cancer metastasis
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Arachadonic Acid; Cancer Testes Antigens; Epigenetics; Fatty Acid Binding Protein 12; Fatty Acid Metabolism; Histone Acetylation; Histone Crotonylation; Lipid Transport; Metastasis; Prostate Cancer
Abstract
Fatty acid binding protein 12 (FABP12) is the most recently discovered member of the FABP family and is important for the movement of fat molecules, or lipids, within our cells. Under normal circumstances, FABP12 is only present in the male germ-line cells, or testis, but becomes reactivated in some cancers such as prostate cancer. When expressed in cancer, FABP12 has been shown to aid in a process known as metastasis, a serious progression of the disease that makes the tumour not only harder to treat, but also deadlier. The goal of this research is to further explore the link between FABP12 and prostate cancer metastasis in order to give us a better understanding of how these tumours spread in the body, as well as look for new possible targets for cancer therapy. This will involve identifying the specific lipids that FABP12 binds to, as well as the effect that these lipids have on the ability of cancer cells to produce the much needed energy that sustains their rapid growth. In addition, this proposal aims to explore the effect of FABP12 on epigenetics, a process whereby genes are turned on and off without the gene itself being altered. The expression of FABP12 seems to be associated with an increase in molecules that are important in the flipping of these on and off switches. Intriguingly, the presence of FABP12 in prostate cancer is also associated with the expression of epigenetically-regulated Cancer Testis Antigens, which like FABP12, are normally only found in the testis. Thus, FABP12 or other Cancer Testis Antigens represent exciting new targets for therapy since they are turned off in almost all healthy tissues. A deeper understanding of the role of FABP12 in prostate cancer may help us identify specific targets for cancer therapy in the future.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Semeniuk, Mitchell
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~